Myriad Genetics, Inc. has promoted Ben Wheeler to chief financial officer, effective August 16, 2025. Wheeler, who has been with the company for over 13 years, was previously the CFO of operations. Scott Leffler, the previous CFO, will now serve as a consultant until September 2. The company also confirmed its full-year outlook as announced on August 5.

Read more at Nasdaq: Myriad Genetics Appoints Ben Wheeler As Chief Financial Officer